Amneal Pharmaceuticals, Inc.
AMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723128
In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.
Holders of 5% or more of AMRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Amneal Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Patel Tushar Bhikhubhai | 13D/A | 15.70%48.6M shares | – | Mar 17, 20251 filing | Mar 17, 2025 | SEC |
| Patel Chintu | 13D/A | 8.20%25.9M shares | – | Oct 7, 20251 filing | Oct 7, 2025 | SEC |
| Patel Chirag K. | 13D/A | 7.10%22.2M shares | – | Aug 8, 20251 filing | Aug 8, 2025 | SEC |
| Mahesh Akram | 13G/A | 6.56%20.6M shares | – | May 14, 20251 filing | May 14, 2025 | SEC |
| Patel Dipan | 13D/A | 5.40%16.9M shares | −2.20 ppfrom 7.60% | Jan 23, 20253 filings | Mar 26, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Amneal Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20266:23 PM ET | Patel Dipan | 13D/A | 5.40%16.9M shares | −2.20 ppfrom 7.60% | Dec 31, 2025 | SEC |
| Mar 26, 20263:43 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.02 ppfrom 5.02%Below 5% | Mar 13, 2026 | SEC |
| Oct 7, 20257:51 PM ET | Patel Chintu | 13D/A | 8.20%25.9M shares | – | Oct 3, 2025 | SEC |
| Oct 6, 20253:05 PM ET | Patel Dipan | 13D/A | 7.60%23.8M shares | −0.10 ppfrom 7.70% | Oct 3, 2025 | SEC |
| Aug 8, 20259:38 PM ET | Patel Chirag K. | 13D/A | 7.10%22.2M shares | – | Aug 6, 2025 | SEC |
| May 14, 20255:03 PM ET | Mahesh Akram | 13G/A | 6.56%20.6M shares | – | Mar 31, 2025 | SEC |
| Apr 30, 20251:56 PM ET | Vanguard Group Inc | 13G | 5.02%15.8M shares | New | Mar 31, 2025 | SEC |
| Mar 17, 20254:45 PM ET | Patel Tushar Bhikhubhai | 13D/A | 15.70%48.6M shares | – | Mar 14, 2025 | SEC |
| Feb 10, 20258:59 AM ET | UBS Group AG | 13G/A | – | – | Dec 31, 2024 | SEC |
| Jan 23, 20255:49 PM ET | Patel Dipan | 13D/A | 7.70%23.8M shares | – | Nov 13, 2024 | SEC |
| Oct 30, 202411:04 AM ET | UBS Group AG | 13G | 6.90%21.5M shares | New | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Amneal Pharmaceuticals, Inc. shares.
No Form 144 notices for Amneal Pharmaceuticals, Inc. are on file.